A photo of Michael Henrickson.

Director of Telemedicine, Division of Rheumatology

Associate Professor, UC Department of PediatricsProfessor, University of Kentucky College of Medicine

513-636-4676

Board Certified

Best Doctors logo

Make an Appointment

My Biography & Research

Biography

Dr. Henrickson has an abiding interest in serving as an advocate for his patients to ensure their complete health needs are addressed. He seeks to know the health care priorities of his patients and families and to fulfill them. To provide improved access to care for the limited resource of pediatric rheumatology, a priority for him is the development of telehealth capacity: tele-rheumatology.

Clinical Interests

Telehealth; health policy; global health; neuropsychiatric-SLE; periodic fever syndromes; systemic JIA; culturally appropriate care.

Research Interests

Ongoing clinical research trials, as a feature of the Division of Rheumatology's translational research focus; telemedicine (tele-rheumatology).

Academic Affiliation

Associate Professor, UC Department of PediatricsProfessor, University of Kentucky College of Medicine

Departments

Rheumatology, Lupus, Rheumatology

My Locations

My Education

BA: magna cum laude, Emory University, Atlanta, GA, 1980.

MD: Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, 1984.

MPH: College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2009.

Residency: Pediatrics, Department of Pediatrics, Tripler Army Medical Center, Honolulu, HI, 1984-87.

Fellowship: Pediatric Rheumatology, Division of Rheumatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 1991-94.

Certification: American Board of Pediatrics: General Pediatrics, 1988 (recertified 2014); Pediatric Rheumatology, 1994 (recertified 2008); National Board of Public Health Examiners, 2009.

My Publications

Loss or Gain of Function Mutations in ACOX1 Cause Axonal Loss Via Different Mechanisms. Chung, H; Wangler, MF; Marcogliese, P; Jo, J; Ravenscoft, T; Duraine, L; Sadeghzadeh, S; Li-Kroeger, D; Schmidt, RE; Pestronk, A; et al. 2019.

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups. Rothwell, S; Chinoy, H; Lamb, JA; Miller, FW; Rider, LG; Wedderburn, LR; McHugh, NJ; Mammen, AL; Betteridge, ZE; Tansley, SL; et al. Annals of the Rheumatic Diseases. 2019; 78:996-1002.

American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus. Brunner, HI; Holland, MJ; Beresford, MW; Ardoin, SP; Appenzeller, S; Silva, CA; Flores, F; Aydin, PO A; Wenderfer, SE; Levy, DM; et al. Arthritis Care and Research. 2019; 71:579-590.

Validation of the Cutaneous Lupus Erythematosus Disease Area and Severity Index and pSkindex27 for use in childhood-onset systemic lupus erythematosus. Ale'Ed, A; Aydin, PO A; Al Mutairi, N; Alsaleem, A; Sonmez, HE; Henrickson, M; Huggins, JL; Ozen, S; Al-Mayouf, SM; Brunner, HI. Lupus Science and Medicine. 2018; 5:e000275-e000275.

A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. Patel, ZH; Lu, X; Miller, D; Forney, CR; Lee, J; Lynch, A; Schroeder, C; Parks, L; Magnusen, AF; Chen, X; et al. Human Molecular Genetics. 2018; 27:2392-2404.

Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients. Kishi, T; Rider, LG; Pak, K; Barillas-Arias, L; Henrickson, M; McCarthy, PL; Shaham, B; Weiss, PF; Horkayne-Szakaly, I; Targoff, IN; et al. Arthritis Care and Research. 2017; 69:1088-1094.

Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation. Henrickson, M; Wang, H. Clinical Rheumatology. 2017; 36:1445-1451.

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Rider, LG; Bayat, N; Feldman, BM; Cimaz, R; Cuttica, RJ; de Oliveira, SK; Lindsley, CB; Pilkington, CA; Reed, AM; Rouster-Stevens, K; et al. Arthritis and Rheumatology. 2017; 69:911-923.

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Rider, LG; Aggarwal, R; Pistorio, A; Bayat, N; Erman, B; Feldman, BM; Huber, AM; Cimaz, R; Cuttica, RJ; de Oliveira, SK; et al. Annals of the Rheumatic Diseases. 2017; 76:782-791.

2010 American College of Rheumatology Adult Fibromyalgia Criteria for Use in an Adolescent Female Population with Juvenile Fibromyalgia. Ting, TV; Barnett, K; Lynch-Jordan, A; Whitacre, C; Henrickson, M; Kashikar-Zuck, S. The Journal of Pediatrics. 2016; 169:181-7.e1.